Pliant Therapeutics Presents Data from its Bexotegrast

SOUTH SAN FRANCISCO, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader...

Related Keywords

California ,United States ,American ,Jonathang Goldin ,Los Angeles ,Gregoryp Cosgrove ,Christopher Keenan ,Martinl Decaris ,Youtube ,Drug Administration ,David Geffen School Of Medicine ,International Conference ,Corporate Communications ,American Thoracic Society ,Translational Sciences At Pliant ,Linkedin ,Nasdaq ,Facebook ,Pliant Therapeutics Inc ,University Of California ,European Medicines Agency ,Clinical Development At Pliant Therapeutics ,Chief Medical Officer ,Vice President ,Clinical Development ,Pliant Therapeutics ,Principal Scientist ,Senior Director ,Translational Sciences ,Biomedical Physics ,David Geffen School ,Fast Track Designation ,Orphan Drug Designation ,Media Contact ,Investor Relations ,